Ionis Pharmaceuticals | IONS - Passifs Courants





Passifs Courants Changement Date
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Arrowhead Research USD 283.35M 11.87M 2026-06
Astellas Pharma JPY 1.1T 134.96B 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Celltrion KRW 288.01B 4.7B 2026-06
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Exelixis USD 411.88M 49.95M 2026-09
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.03B 506M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Omeros USD 85.5M 2.28M 2025-06
OPKO Health USD 149.37M 984K 2026-06
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 31.73B 920M 2026-09
Pharma Mar EUR 125.39M 26.97M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 259.32M 8.32M 2025-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09